Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pharmacokinetic Analysis of a von Willebrand Factor/Factor VIII (VWF/FVIII) Concentrate in Adults and Children with von Willebrand Disease (VWD).

Jorge Di Paola, MD, Stephan Lethagen, MD, PhD, Joan Gill, MD, Pier Mannucci, MD, Jonathan Bernstein, MD, William Nichols, MD, Carl Friedman, MD, Sigurd Knaub, PhD, Garrett Bergman, MD

Blood (2007) 110 (11): 2140.

https://doi.org/10.1182/blood.V110.11.2140.2140

Published: 2007

Journal Articles

Successful Treatment of Factor IX Inhibitor Complicated by Nephrotic Syndrome with Rituxan.

Jonathan Bernstein, MD, Neepa Gupta, MD, Rebecca Berkowitz, RN

Blood (2007) 110 (11): 3971.

https://doi.org/10.1182/blood.V110.11.3971.3971

Published: 2007

Journal Articles

von Willebrand Factor/Factor VIII Concentrate (Humate-P®) Is Safe and Effective in the Prevention of Perioperative Bleeding in Patients with Very Low von Willebrand Factor: Ristocetin Cofactor (VWF:RCo).

Joan Cox Gill, MD, Cindy A. Leissinger, MD, Jorge DiPaola, MD, Jonathan Bernstein, MD, Margaret V. Ragni, MD, Rinah Shopnick, MD, Leonard A. Valentino, MD, Sigurd Knaub, PhD, Carl Friedman, MD

Blood (2006) 108 (11): 4071.

https://doi.org/10.1182/blood.V108.11.4071.4071

Published: 2006

Journal Articles

Safety and Efficacy of Von Willebrand Factor/Factor VIII Concentrate (Humate-P®) for Prophylaxis of Excessive Bleeding during Elective Surgery in Patients with von Willebrand Disease.

Jonathan Bernstein, MD, Joan Cox Gill, MD, Cindy A. Leissinger, MD, Jorge Di Paola, MD, Margaret V. Ragni, MD, Rinah Shopnick, MD, Leonard A. Valentino, MD, Carl Friedman, MD, Sigurd Knaub, MD, Humate P Study Group

Blood (2006) 108 (11): 4076.

https://doi.org/10.1182/blood.V108.11.4076.4076

Published: 2006

Journal Articles

Pharmacokinetic Evaluation of Von Willebrand Factor/Factor VIII Concentrate (Humate-P®) Prior to Elective Surgery in Patients with Von Willebrand Disease.

Jorge Di Paola, MD, Joan Gill, MD, Jonathan Bernstein, MD, Cindy Leissinger, MD, Margaret Ragni, MD, Rinah Shopnik, MD, Leonard Valentino, MD, Carl Friedman, MD, Sigurd Knaub, MD

Blood (2006) 108 (11): 4077.

https://doi.org/10.1182/blood.V108.11.4077.4077

Published: 2006

NARROW

Pharmacokinetic Analysis of a von Willebrand Factor/Factor VIII (VWF/FVIII) Concentrate in Adults and Children with von Willebrand Disease (VWD).

Successful Treatment of Factor IX Inhibitor Complicated by Nephrotic Syndrome with Rituxan.

von Willebrand Factor/Factor VIII Concentrate (Humate-P®) Is Safe and Effective in the Prevention of Perioperative Bleeding in Patients with Very Low von Willebrand Factor: Ristocetin Cofactor (VWF:RCo).

Safety and Efficacy of Von Willebrand Factor/Factor VIII Concentrate (Humate-P®) for Prophylaxis of Excessive Bleeding during Elective Surgery in Patients with von Willebrand Disease.

Pharmacokinetic Evaluation of Von Willebrand Factor/Factor VIII Concentrate (Humate-P®) Prior to Elective Surgery in Patients with Von Willebrand Disease.

Email alerts

ASH Publications

American Society of Hematology

Pharmacokinetic Analysis of a von Willebrand Factor/Factor VIII (VWF/FVIII) Concentrate in Adults and Children with von Willebrand Disease (VWD).

Successful Treatment of Factor IX Inhibitor Complicated by Nephrotic Syndrome with Rituxan.

von Willebrand Factor/Factor VIII Concentrate (Humate-P®) Is Safe and Effective in the Prevention of Perioperative Bleeding in Patients with Very Low von Willebrand Factor: Ristocetin Cofactor (VWF:RCo).

Safety and Efficacy of Von Willebrand Factor/Factor VIII Concentrate (Humate-P®) for Prophylaxis of Excessive Bleeding during Elective Surgery in Patients with von Willebrand Disease.

Pharmacokinetic Evaluation of Von Willebrand Factor/Factor VIII Concentrate (Humate-P®) Prior to Elective Surgery in Patients with Von Willebrand Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only